Suchergebnisse - (Person:"Liao, Xuejiao")

PubPharm (16)

1

Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination

enthalten in: Emerging microbes & infections | 2023

von Wang, M. | Zhou, B. | Fan, Q. | +9

2

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine

enthalten in: Frontiers in immunology | 2023

von He, X. | Cao, Y. | Lu, Y. | +9

3

Long-term sequelae of different COVID-19 variants : The original strain versus the Omicron variant

enthalten in: Global health & medicine | 2022

von Liao, X. | Guan, Y. | Liao, Q. | +11

4

Neutralizing monoclonal antibody in patients with coronavirus disease 2019 : an observational study

enthalten in: Virology journal | 2022

von Liao, X. | Li, D. | Liu, J. | +8

5

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study

enthalten in: Virology journal | 2022

von Liao, X. | Li, D. | Liu, J. | +8

6

Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study

enthalten in: Virology journal | 2022

von Liao, X. | Li, D. | Liu, J. | +8

7

Healthy outcomes of patients with COVID-19 two years after the infection : a prospective cohort study

enthalten in: Emerging microbes & infections | 2022

von Li, D. | Liao, X. | Liu, Z. | +9

8

12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19 : A Single-Center Prospective Cohort Study

enthalten in: Frontiers in cellular and infection microbiology | 2022

von Liao, X. | Li, D. | Ma, Z. | +6

9

Three-Month Pulmonary Function and Radiological Outcomes in COVID-19 Survivors : A Longitudinal Patient Cohort Study

enthalten in: Open forum infectious diseases | 2021

von Liao, X. | Wang, Y. | He, Z. | +8

10

Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers

enthalten in: Frontiers in medicine | 2021

von Xiao, T. | Wang, Y. | Yuan, J. | +8